e-learning
resources
Vienna 2012
Monday, 03.09.2012
Pharmacological and non-pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Target lobar volume reduction and COPD outcome measures after endobronchial one-way valve therapy
A. Valipour, F.J.F. Herth, G.J. Criner, J.M. Vergnon, J. Goldin, F. Sciurba, A. Ernst (Vienna, Austria; Heidelberg, Germany; Philadelphia, Los Angeles, , Boston, United States Of America; Saint Etienne, France)
Source:
Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Session:
Pharmacological and non-pharmacological management of COPD
Session type:
Poster Discussion
Number:
2899
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Valipour, F.J.F. Herth, G.J. Criner, J.M. Vergnon, J. Goldin, F. Sciurba, A. Ernst (Vienna, Austria; Heidelberg, Germany; Philadelphia, Los Angeles, , Boston, United States Of America; Saint Etienne, France). Target lobar volume reduction and COPD outcome measures after endobronchial one-way valve therapy. Eur Respir J 2012; 40: Suppl. 56, 2899
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy
Source: Eur Respir J 2014; 43: 387-396
Year: 2013
Comparative assessment of endobronchial valve lung volume reduction in patients with COPD
Source: Annual Congress 2012 - Mediastinum and tracheobronchial tree
Year: 2012
Minimal important difference of lobar volume reduction after valve treatment for emphysema
Source: International Congress 2017 – Interventional pulmonology highlights 2017
Year: 2017
The effect of bronchoscopic lung volume reduction treatment on pulmonary ventilation and perfusion: comparison of valve and coil methods
Source: International Congress 2017 – Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD)
Year: 2017
Quantitative CT analysis of fissure integrity and emphysema heterogeneity for one-way valve treatment; Analysis in Japanese COPD patients
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020
Regional fissure integrity analysis for improved prediction of endobronchial valve lung volume reduction therapy
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015
Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Chartis evaluation of collateral ventilation versus HRCT assessment, in predicting clinical outcomes following endobronchial valve therapy (EBV) in COPD patients
Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Year: 2012
Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment
Source: Eur Respir J 2013; 41: 302-308
Year: 2013
Lung volume reduction surgery after endobronchial valve treatment
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020
Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Treatment of persistent air leaks with one-way endobronchial valves
Source: Eur Respir J 2006; 28: Suppl. 50, 597s
Year: 2006
Management of severe COPD patients using bronchoscopic valve lung volume reduction: Preliminary results
Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction
Year: 2011
The minimal important difference for target lobe volume reduction following endoscopic valve therapy in patients with advanced emphysema
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Short term outcome of lung volume reduction with endobronchial valves in emphysema patients with a very low diffusion capacity
Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news
Year: 2019
Pulmonary functional tests in patients with severe COPD after lung volume reduction surgery
Source: Eur Respir J 2002; 20: Suppl. 38, 606s
Year: 2002
CT assessment of lobar heterogenity and fissure integrity in pulmonary emphysema for bronchoscopic lung volume reduction with valve
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015
Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Segmental lung volume reduction (LVR) with vapor better targets disease heterogeneity as compared to lobar LVR
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept